| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 28 | 2024 | 1292 | 4.200 |
Why?
|
| Premature Birth | 20 | 2024 | 1782 | 2.320 |
Why?
|
| Gynecologic Surgical Procedures | 14 | 2021 | 284 | 2.110 |
Why?
|
| Pregnancy Rate | 15 | 2021 | 648 | 2.050 |
Why?
|
| Pregnancy | 146 | 2024 | 29876 | 1.990 |
Why?
|
| Pregnancy Outcome | 29 | 2024 | 2922 | 1.960 |
Why?
|
| Live Birth | 14 | 2023 | 511 | 1.790 |
Why?
|
| Abortion, Induced | 6 | 2022 | 462 | 1.730 |
Why?
|
| Embryo Transfer | 11 | 2024 | 522 | 1.600 |
Why?
|
| Infertility | 15 | 2023 | 654 | 1.560 |
Why?
|
| Obstetrics | 14 | 2022 | 665 | 1.530 |
Why?
|
| Placenta Diseases | 4 | 2022 | 199 | 1.510 |
Why?
|
| Placenta Accreta | 5 | 2022 | 237 | 1.490 |
Why?
|
| Placenta | 11 | 2023 | 1709 | 1.470 |
Why?
|
| Pelvic Organ Prolapse | 12 | 2022 | 112 | 1.390 |
Why?
|
| Gynecology | 11 | 2022 | 526 | 1.380 |
Why?
|
| Preimplantation Diagnosis | 5 | 2023 | 143 | 1.190 |
Why?
|
| Genital Neoplasms, Female | 6 | 2024 | 532 | 1.170 |
Why?
|
| Cervix Uteri | 8 | 2024 | 570 | 1.090 |
Why?
|
| Abortion, Legal | 2 | 2018 | 114 | 1.060 |
Why?
|
| Maternal Age | 8 | 2022 | 809 | 0.990 |
Why?
|
| Hemophilia A | 6 | 2007 | 360 | 0.890 |
Why?
|
| Female | 235 | 2024 | 392688 | 0.880 |
Why?
|
| Costs and Cost Analysis | 2 | 2021 | 1668 | 0.850 |
Why?
|
| Delivery, Obstetric | 12 | 2021 | 940 | 0.830 |
Why?
|
| Oocyte Donation | 2 | 2019 | 52 | 0.810 |
Why?
|
| Gestational Age | 16 | 2024 | 3577 | 0.800 |
Why?
|
| Cesarean Section | 9 | 2022 | 1398 | 0.770 |
Why?
|
| Suburethral Slings | 8 | 2020 | 72 | 0.750 |
Why?
|
| Postpartum Hemorrhage | 3 | 2019 | 272 | 0.750 |
Why?
|
| Insurance | 1 | 2022 | 113 | 0.730 |
Why?
|
| Placenta Previa | 2 | 2019 | 122 | 0.720 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2023 | 384 | 0.720 |
Why?
|
| Pelvic Floor | 6 | 2021 | 137 | 0.700 |
Why?
|
| Contraception Behavior | 4 | 2014 | 182 | 0.690 |
Why?
|
| Birth Rate | 7 | 2020 | 168 | 0.690 |
Why?
|
| Pre-Eclampsia | 10 | 2023 | 1231 | 0.680 |
Why?
|
| Humans | 258 | 2024 | 761578 | 0.670 |
Why?
|
| Ultrasonography, Prenatal | 7 | 2023 | 1755 | 0.670 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2023 | 497 | 0.670 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2023 | 2020 | 0.660 |
Why?
|
| Pain, Postoperative | 7 | 2023 | 1740 | 0.640 |
Why?
|
| Infant, Low Birth Weight | 5 | 2023 | 870 | 0.630 |
Why?
|
| Marijuana Smoking | 1 | 2022 | 258 | 0.620 |
Why?
|
| Government Regulation | 2 | 2013 | 524 | 0.620 |
Why?
|
| Pregnant Women | 2 | 2021 | 566 | 0.610 |
Why?
|
| Counseling | 6 | 2023 | 1547 | 0.610 |
Why?
|
| Adult | 130 | 2024 | 221200 | 0.610 |
Why?
|
| Infant, Newborn | 42 | 2024 | 26198 | 0.590 |
Why?
|
| Blastocyst | 6 | 2020 | 433 | 0.590 |
Why?
|
| Abortion, Spontaneous | 5 | 2023 | 533 | 0.570 |
Why?
|
| Contraception | 4 | 2016 | 349 | 0.570 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2017 | 26 | 0.560 |
Why?
|
| Intrauterine Devices, Copper | 1 | 2017 | 30 | 0.560 |
Why?
|
| Levonorgestrel | 1 | 2017 | 74 | 0.550 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 4016 | 0.540 |
Why?
|
| Research Report | 1 | 2020 | 367 | 0.540 |
Why?
|
| Ischemia | 3 | 2020 | 1884 | 0.540 |
Why?
|
| Retrospective Studies | 68 | 2024 | 80646 | 0.540 |
Why?
|
| Patient Dropouts | 1 | 2018 | 412 | 0.540 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3808 | 0.530 |
Why?
|
| Infant Mortality | 3 | 2019 | 759 | 0.530 |
Why?
|
| Multiple Birth Offspring | 2 | 2012 | 22 | 0.530 |
Why?
|
| Patient Simulation | 4 | 2012 | 298 | 0.520 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 1613 | 0.520 |
Why?
|
| Community Health Centers | 4 | 2017 | 461 | 0.510 |
Why?
|
| Urination Disorders | 4 | 2020 | 238 | 0.510 |
Why?
|
| Pregnancy, Unwanted | 2 | 2014 | 24 | 0.510 |
Why?
|
| Cannabis | 1 | 2022 | 441 | 0.510 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 5440 | 0.500 |
Why?
|
| After-Hours Care | 1 | 2016 | 102 | 0.490 |
Why?
|
| Congresses as Topic | 1 | 2020 | 803 | 0.480 |
Why?
|
| Patient Care Team | 4 | 2020 | 2521 | 0.480 |
Why?
|
| Streptococcus agalactiae | 2 | 2019 | 337 | 0.470 |
Why?
|
| Endometrium | 1 | 2017 | 403 | 0.470 |
Why?
|
| Patient Satisfaction | 7 | 2022 | 3461 | 0.460 |
Why?
|
| Air Pollutants | 6 | 2024 | 2896 | 0.460 |
Why?
|
| Obstetric Labor Complications | 2 | 2017 | 236 | 0.460 |
Why?
|
| Health Personnel | 4 | 2016 | 3335 | 0.450 |
Why?
|
| Pregnancy Complications | 12 | 2024 | 2947 | 0.440 |
Why?
|
| Health Status Disparities | 4 | 2019 | 1852 | 0.440 |
Why?
|
| Leadership | 3 | 2017 | 1385 | 0.430 |
Why?
|
| Molecular Imaging | 1 | 2020 | 815 | 0.420 |
Why?
|
| Maternal Exposure | 8 | 2024 | 1067 | 0.420 |
Why?
|
| Progesterone | 3 | 2024 | 742 | 0.410 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 495 | 0.400 |
Why?
|
| Aneuploidy | 6 | 2023 | 552 | 0.390 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 142 | 0.390 |
Why?
|
| Streptococcal Infections | 2 | 2019 | 617 | 0.390 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 709 | 0.390 |
Why?
|
| Cardiotocography | 1 | 2011 | 24 | 0.380 |
Why?
|
| United States | 32 | 2024 | 72335 | 0.380 |
Why?
|
| Prenatal Care | 4 | 2024 | 1139 | 0.380 |
Why?
|
| Cross-Sectional Studies | 28 | 2024 | 26127 | 0.380 |
Why?
|
| Cosmetics | 2 | 2023 | 102 | 0.380 |
Why?
|
| Heart Rate, Fetal | 1 | 2011 | 75 | 0.380 |
Why?
|
| Urinary Incontinence, Stress | 4 | 2016 | 181 | 0.380 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2023 | 115 | 0.370 |
Why?
|
| Pregnancy, Multiple | 3 | 2022 | 215 | 0.370 |
Why?
|
| Stress, Psychological | 5 | 2019 | 4481 | 0.370 |
Why?
|
| Depression | 6 | 2023 | 8124 | 0.360 |
Why?
|
| Internet | 3 | 2022 | 3093 | 0.360 |
Why?
|
| Knowledge | 1 | 2012 | 177 | 0.360 |
Why?
|
| Hemarthrosis | 2 | 2007 | 39 | 0.350 |
Why?
|
| Ambulatory Care | 3 | 2020 | 2775 | 0.350 |
Why?
|
| Social Class | 3 | 2018 | 2004 | 0.350 |
Why?
|
| Hypotension | 1 | 2016 | 879 | 0.340 |
Why?
|
| Clinical Competence | 8 | 2022 | 4793 | 0.340 |
Why?
|
| Infertility, Female | 4 | 2021 | 760 | 0.340 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2019 | 461 | 0.340 |
Why?
|
| Urinary Incontinence | 5 | 2019 | 489 | 0.340 |
Why?
|
| Urination | 3 | 2016 | 203 | 0.340 |
Why?
|
| Reproductive Medicine | 2 | 2022 | 99 | 0.330 |
Why?
|
| Income | 2 | 2019 | 1877 | 0.330 |
Why?
|
| Laparoscopy | 8 | 2021 | 2036 | 0.330 |
Why?
|
| MicroRNAs | 2 | 2022 | 3816 | 0.330 |
Why?
|
| Boston | 15 | 2024 | 9326 | 0.330 |
Why?
|
| Referral and Consultation | 4 | 2024 | 3600 | 0.320 |
Why?
|
| Environmental Exposure | 4 | 2024 | 4485 | 0.320 |
Why?
|
| Hysterectomy | 5 | 2019 | 857 | 0.320 |
Why?
|
| Birth Weight | 9 | 2023 | 2103 | 0.320 |
Why?
|
| Cohort Studies | 28 | 2024 | 41493 | 0.310 |
Why?
|
| Birth Order | 2 | 2019 | 95 | 0.310 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2016 | 731 | 0.310 |
Why?
|
| Food Supply | 2 | 2024 | 544 | 0.310 |
Why?
|
| Cervical Length Measurement | 3 | 2024 | 45 | 0.310 |
Why?
|
| Young Adult | 39 | 2024 | 59254 | 0.310 |
Why?
|
| Ovulation Induction | 5 | 2021 | 277 | 0.300 |
Why?
|
| Prospective Studies | 29 | 2024 | 54423 | 0.300 |
Why?
|
| Placentation | 2 | 2019 | 78 | 0.300 |
Why?
|
| Prenatal Diagnosis | 4 | 2020 | 1265 | 0.290 |
Why?
|
| Mothers | 7 | 2020 | 2198 | 0.290 |
Why?
|
| Uterine Prolapse | 2 | 2021 | 68 | 0.290 |
Why?
|
| Fetal Development | 5 | 2023 | 769 | 0.290 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2759 | 0.280 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2024 | 83 | 0.280 |
Why?
|
| Attitude to Health | 4 | 2018 | 2025 | 0.280 |
Why?
|
| Obstetric Labor, Premature | 2 | 2019 | 272 | 0.280 |
Why?
|
| Myofascial Pain Syndromes | 2 | 2019 | 37 | 0.270 |
Why?
|
| Attitude of Health Personnel | 4 | 2020 | 3889 | 0.270 |
Why?
|
| Directive Counseling | 3 | 2020 | 170 | 0.270 |
Why?
|
| Solar Activity | 2 | 2023 | 44 | 0.270 |
Why?
|
| Fertility | 5 | 2023 | 771 | 0.260 |
Why?
|
| Equipment Contamination | 1 | 2007 | 182 | 0.260 |
Why?
|
| Air Pollution | 3 | 2024 | 2359 | 0.250 |
Why?
|
| Middle Aged | 58 | 2024 | 220917 | 0.250 |
Why?
|
| Hemophilia B | 1 | 2006 | 84 | 0.250 |
Why?
|
| Cost of Illness | 5 | 2024 | 1936 | 0.250 |
Why?
|
| Lead | 2 | 2022 | 879 | 0.250 |
Why?
|
| Particulate Matter | 5 | 2024 | 2605 | 0.250 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 4420 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2020 | 558 | 0.250 |
Why?
|
| Teaching | 2 | 2015 | 1170 | 0.250 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 583 | 0.250 |
Why?
|
| Joints | 1 | 2007 | 322 | 0.240 |
Why?
|
| Diabetes, Gestational | 3 | 2021 | 1248 | 0.240 |
Why?
|
| Botswana | 3 | 2023 | 1048 | 0.240 |
Why?
|
| Students, Medical | 2 | 2023 | 1936 | 0.240 |
Why?
|
| Ploidies | 3 | 2010 | 285 | 0.240 |
Why?
|
| Cisplatin | 3 | 2020 | 1652 | 0.240 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2023 | 2518 | 0.240 |
Why?
|
| Health Care Surveys | 3 | 2013 | 2426 | 0.240 |
Why?
|
| Mass Screening | 7 | 2022 | 5428 | 0.230 |
Why?
|
| Pelvic Pain | 2 | 2019 | 298 | 0.230 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 4028 | 0.230 |
Why?
|
| Parity | 4 | 2022 | 927 | 0.230 |
Why?
|
| Fetal Blood | 3 | 2021 | 1347 | 0.230 |
Why?
|
| Hospitalization | 4 | 2021 | 10721 | 0.230 |
Why?
|
| Prevalence | 11 | 2023 | 15732 | 0.230 |
Why?
|
| Cerclage, Cervical | 1 | 2024 | 31 | 0.230 |
Why?
|
| Acetic Acid | 1 | 2023 | 60 | 0.230 |
Why?
|
| Postpartum Period | 4 | 2024 | 1173 | 0.220 |
Why?
|
| House Calls | 2 | 2022 | 161 | 0.220 |
Why?
|
| Massachusetts | 11 | 2024 | 8830 | 0.220 |
Why?
|
| Quality Improvement | 5 | 2019 | 3801 | 0.220 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2019 | 237 | 0.210 |
Why?
|
| Critical Illness | 1 | 2016 | 2723 | 0.210 |
Why?
|
| Family Planning Services | 3 | 2014 | 268 | 0.210 |
Why?
|
| Colposcopy | 1 | 2023 | 150 | 0.210 |
Why?
|
| Infant | 16 | 2024 | 36193 | 0.210 |
Why?
|
| Case-Control Studies | 16 | 2022 | 22176 | 0.210 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 935 | 0.210 |
Why?
|
| Odds Ratio | 6 | 2018 | 9646 | 0.210 |
Why?
|
| Placental Circulation | 2 | 2020 | 37 | 0.210 |
Why?
|
| Environmental Pollutants | 2 | 2022 | 1277 | 0.210 |
Why?
|
| Endometrial Hyperplasia | 1 | 2023 | 97 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3744 | 0.200 |
Why?
|
| Social Stigma | 3 | 2019 | 769 | 0.200 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 526 | 0.200 |
Why?
|
| Treatment Outcome | 25 | 2021 | 64684 | 0.200 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2024 | 189 | 0.200 |
Why?
|
| Progestins | 1 | 2024 | 301 | 0.200 |
Why?
|
| Vagina | 4 | 2022 | 838 | 0.200 |
Why?
|
| Anxiety | 5 | 2023 | 4573 | 0.200 |
Why?
|
| Vaginal Neoplasms | 1 | 2022 | 104 | 0.200 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2019 | 518 | 0.200 |
Why?
|
| Endocrine Disruptors | 2 | 2024 | 264 | 0.200 |
Why?
|
| Dystocia | 2 | 2012 | 33 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2021 | 2151 | 0.200 |
Why?
|
| Surgical Instruments | 2 | 2018 | 383 | 0.190 |
Why?
|
| Internship and Residency | 5 | 2022 | 5882 | 0.190 |
Why?
|
| Oils | 1 | 2021 | 56 | 0.190 |
Why?
|
| Genetic Testing | 6 | 2023 | 3537 | 0.190 |
Why?
|
| Hair Preparations | 1 | 2021 | 32 | 0.190 |
Why?
|
| Pilot Projects | 10 | 2024 | 8633 | 0.190 |
Why?
|
| Resilience, Psychological | 2 | 2020 | 788 | 0.190 |
Why?
|
| Sepsis | 2 | 2014 | 2585 | 0.190 |
Why?
|
| Insurance, Health | 4 | 2022 | 2498 | 0.180 |
Why?
|
| Search Engine | 1 | 2022 | 143 | 0.180 |
Why?
|
| Education, Medical | 2 | 2012 | 1725 | 0.180 |
Why?
|
| Cryopreservation | 3 | 2020 | 728 | 0.180 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 184 | 0.180 |
Why?
|
| Micronutrients | 1 | 2024 | 382 | 0.180 |
Why?
|
| Incidence | 12 | 2021 | 21355 | 0.180 |
Why?
|
| Urinary Catheterization | 2 | 2019 | 193 | 0.180 |
Why?
|
| Faculty, Medical | 3 | 2020 | 1204 | 0.180 |
Why?
|
| Informed Consent | 2 | 2020 | 1008 | 0.180 |
Why?
|
| Physical Examination | 1 | 2007 | 1255 | 0.180 |
Why?
|
| Embryo Implantation | 3 | 2013 | 270 | 0.180 |
Why?
|
| Physician-Patient Relations | 2 | 2024 | 3249 | 0.180 |
Why?
|
| Teaching Materials | 1 | 2020 | 84 | 0.180 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3201 | 0.180 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2021 | 137 | 0.180 |
Why?
|
| Nuclear Medicine | 2 | 2020 | 237 | 0.180 |
Why?
|
| DNA Methylation | 3 | 2020 | 4399 | 0.180 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2024 | 357 | 0.180 |
Why?
|
| Placental Insufficiency | 1 | 2020 | 50 | 0.170 |
Why?
|
| Anal Canal | 2 | 2021 | 373 | 0.170 |
Why?
|
| Labor, Induced | 2 | 2018 | 151 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2024 | 3113 | 0.170 |
Why?
|
| Infection Control | 1 | 2007 | 982 | 0.170 |
Why?
|
| Health Policy | 3 | 2022 | 2684 | 0.170 |
Why?
|
| Audiovisual Aids | 1 | 2020 | 99 | 0.170 |
Why?
|
| Shoulder | 2 | 2012 | 300 | 0.170 |
Why?
|
| Blood Coagulation Factors | 2 | 2001 | 365 | 0.170 |
Why?
|
| Radioactivity | 1 | 2020 | 59 | 0.170 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2019 | 28 | 0.170 |
Why?
|
| Phyllodes Tumor | 1 | 2019 | 53 | 0.170 |
Why?
|
| Time Factors | 14 | 2021 | 39970 | 0.170 |
Why?
|
| Austria | 1 | 2020 | 207 | 0.170 |
Why?
|
| Colitis, Ulcerative | 3 | 2017 | 1922 | 0.170 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 131 | 0.170 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2019 | 28 | 0.170 |
Why?
|
| Uterine Neoplasms | 2 | 2020 | 1420 | 0.170 |
Why?
|
| Health Expenditures | 3 | 2023 | 2366 | 0.160 |
Why?
|
| Male | 49 | 2024 | 360841 | 0.160 |
Why?
|
| Reproductive History | 1 | 2020 | 211 | 0.160 |
Why?
|
| Triage | 2 | 2023 | 986 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2021 | 464 | 0.160 |
Why?
|
| International Agencies | 1 | 2020 | 243 | 0.160 |
Why?
|
| Urinary Retention | 3 | 2019 | 106 | 0.160 |
Why?
|
| HIV | 2 | 2023 | 1582 | 0.160 |
Why?
|
| Pericytes | 1 | 2021 | 293 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 305 | 0.160 |
Why?
|
| Human papillomavirus 18 | 1 | 2019 | 125 | 0.160 |
Why?
|
| Birth Intervals | 1 | 2018 | 51 | 0.160 |
Why?
|
| Guideline Adherence | 3 | 2019 | 2220 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 278 | 0.160 |
Why?
|
| Age Factors | 10 | 2019 | 18398 | 0.150 |
Why?
|
| Language | 3 | 2024 | 1540 | 0.150 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3086 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2020 | 748 | 0.150 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 218 | 0.150 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 529 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3206 | 0.150 |
Why?
|
| Policy | 1 | 2022 | 508 | 0.150 |
Why?
|
| Oocytes | 2 | 2022 | 1166 | 0.150 |
Why?
|
| Lymphopenia | 1 | 2020 | 281 | 0.150 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3156 | 0.150 |
Why?
|
| Blood Glucose | 4 | 2024 | 6391 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2016 | 156 | 0.150 |
Why?
|
| Reproductive Health Services | 1 | 2019 | 87 | 0.150 |
Why?
|
| Abdomen | 2 | 2014 | 1128 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 257 | 0.150 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 376 | 0.150 |
Why?
|
| Fellowships and Scholarships | 2 | 2018 | 1117 | 0.150 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2017 | 4 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2012 | 513 | 0.150 |
Why?
|
| Human papillomavirus 16 | 1 | 2019 | 267 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 420 | 0.140 |
Why?
|
| Cyclophosphamide | 2 | 2020 | 2220 | 0.140 |
Why?
|
| Injections | 2 | 2019 | 831 | 0.140 |
Why?
|
| Radionuclide Imaging | 2 | 2020 | 1972 | 0.140 |
Why?
|
| Nurse Practitioners | 2 | 2017 | 271 | 0.140 |
Why?
|
| Body Mass Index | 6 | 2024 | 12953 | 0.140 |
Why?
|
| Critical Pathways | 1 | 2021 | 474 | 0.140 |
Why?
|
| Phthalic Acids | 1 | 2022 | 478 | 0.140 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 361 | 0.140 |
Why?
|
| Single Embryo Transfer | 1 | 2016 | 29 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2020 | 423 | 0.140 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 791 | 0.140 |
Why?
|
| Patient Preference | 1 | 2024 | 924 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2021 | 15633 | 0.140 |
Why?
|
| Milk, Human | 1 | 2021 | 486 | 0.140 |
Why?
|
| Citric Acid | 1 | 2017 | 123 | 0.140 |
Why?
|
| Hot Temperature | 1 | 2023 | 1440 | 0.140 |
Why?
|
| Financing, Personal | 1 | 2019 | 309 | 0.140 |
Why?
|
| Embryonic Development | 3 | 2010 | 721 | 0.140 |
Why?
|
| Pessaries | 1 | 2016 | 15 | 0.130 |
Why?
|
| Sex Reassignment Surgery | 1 | 2019 | 164 | 0.130 |
Why?
|
| Doxorubicin | 2 | 2020 | 2224 | 0.130 |
Why?
|
| Intrauterine Devices | 1 | 2017 | 113 | 0.130 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 406 | 0.130 |
Why?
|
| Enema | 1 | 2017 | 141 | 0.130 |
Why?
|
| Exercise Therapy | 2 | 2021 | 929 | 0.130 |
Why?
|
| Colorado | 2 | 2007 | 165 | 0.130 |
Why?
|
| Neuromuscular Agents | 2 | 2019 | 147 | 0.130 |
Why?
|
| Fibrinogen | 1 | 2019 | 888 | 0.130 |
Why?
|
| Nicotine | 1 | 2021 | 680 | 0.130 |
Why?
|
| Psychometrics | 1 | 2006 | 3065 | 0.130 |
Why?
|
| Communication | 4 | 2023 | 3873 | 0.130 |
Why?
|
| Quinolines | 1 | 2021 | 765 | 0.130 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 273 | 0.130 |
Why?
|
| Cities | 1 | 2018 | 546 | 0.130 |
Why?
|
| Urinary Tract Infections | 2 | 2019 | 802 | 0.130 |
Why?
|
| Insurance Coverage | 3 | 2023 | 1940 | 0.130 |
Why?
|
| Scopolamine | 1 | 2016 | 93 | 0.130 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2017 | 93 | 0.130 |
Why?
|
| Postnatal Care | 2 | 2020 | 262 | 0.130 |
Why?
|
| Coercion | 1 | 2016 | 69 | 0.130 |
Why?
|
| Residence Characteristics | 3 | 2024 | 2095 | 0.130 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 643 | 0.130 |
Why?
|
| Telephone | 1 | 2019 | 627 | 0.130 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 352 | 0.130 |
Why?
|
| Antioxidants | 1 | 2024 | 1668 | 0.130 |
Why?
|
| Cathartics | 1 | 2017 | 127 | 0.130 |
Why?
|
| Protein C | 2 | 2008 | 133 | 0.130 |
Why?
|
| Telomere | 2 | 2018 | 943 | 0.130 |
Why?
|
| Muscarinic Antagonists | 1 | 2016 | 135 | 0.130 |
Why?
|
| Physicians | 4 | 2016 | 4591 | 0.120 |
Why?
|
| Infant, Premature | 2 | 2022 | 2107 | 0.120 |
Why?
|
| Vaginal Smears | 2 | 2015 | 499 | 0.120 |
Why?
|
| Urology | 1 | 2020 | 400 | 0.120 |
Why?
|
| Urinary Bladder Diseases | 1 | 2016 | 167 | 0.120 |
Why?
|
| Chorionic Gonadotropin | 1 | 2017 | 457 | 0.120 |
Why?
|
| Risk Management | 1 | 2018 | 558 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2018 | 429 | 0.120 |
Why?
|
| BCG Vaccine | 1 | 2017 | 369 | 0.120 |
Why?
|
| Family Practice | 1 | 2017 | 512 | 0.120 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 888 | 0.120 |
Why?
|
| Nitrogen Dioxide | 3 | 2023 | 522 | 0.120 |
Why?
|
| Office Visits | 1 | 2019 | 595 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1844 | 0.120 |
Why?
|
| Risk Factors | 19 | 2022 | 74212 | 0.120 |
Why?
|
| Sex Offenses | 2 | 2015 | 352 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2020 | 851 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 753 | 0.120 |
Why?
|
| Clomiphene | 1 | 2014 | 71 | 0.120 |
Why?
|
| Rape | 1 | 2015 | 131 | 0.120 |
Why?
|
| Subcutaneous Tissue | 1 | 2014 | 132 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3801 | 0.110 |
Why?
|
| Hospitals | 3 | 2017 | 3882 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 637 | 0.110 |
Why?
|
| Depression, Postpartum | 2 | 2009 | 346 | 0.110 |
Why?
|
| Emotions | 2 | 2023 | 2739 | 0.110 |
Why?
|
| Fertility Agents, Female | 1 | 2014 | 101 | 0.110 |
Why?
|
| Parental Notification | 1 | 2013 | 12 | 0.110 |
Why?
|
| Adolescent | 19 | 2024 | 88323 | 0.110 |
Why?
|
| Crohn Disease | 2 | 2017 | 2279 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2018 | 617 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 543 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1366 | 0.110 |
Why?
|
| Insemination, Artificial | 1 | 2014 | 99 | 0.110 |
Why?
|
| Mycoplasma genitalium | 1 | 2013 | 12 | 0.110 |
Why?
|
| Lymph Node Excision | 2 | 2018 | 1271 | 0.110 |
Why?
|
| Colonic Pouches | 1 | 2014 | 122 | 0.110 |
Why?
|
| Stillbirth | 1 | 2016 | 368 | 0.110 |
Why?
|
| Civil Rights | 1 | 2014 | 132 | 0.110 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39107 | 0.110 |
Why?
|
| Glucose Tolerance Test | 3 | 2024 | 1178 | 0.110 |
Why?
|
| Third-Party Consent | 1 | 2013 | 66 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12149 | 0.110 |
Why?
|
| Sex Factors | 6 | 2018 | 10554 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2016 | 2690 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 647 | 0.110 |
Why?
|
| Antithrombins | 2 | 2008 | 294 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2020 | 1403 | 0.110 |
Why?
|
| Mycoplasma Infections | 1 | 2013 | 120 | 0.110 |
Why?
|
| Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
| Phosphates | 1 | 2017 | 770 | 0.110 |
Why?
|
| Video Recording | 1 | 2018 | 967 | 0.110 |
Why?
|
| Postoperative Period | 4 | 2020 | 1814 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2017 | 3442 | 0.110 |
Why?
|
| Religion | 1 | 2016 | 372 | 0.110 |
Why?
|
| Abortion Applicants | 1 | 2012 | 5 | 0.110 |
Why?
|
| Longitudinal Ligaments | 1 | 2012 | 25 | 0.110 |
Why?
|
| Pelvis | 1 | 2017 | 733 | 0.110 |
Why?
|
| Propensity Score | 1 | 2020 | 1913 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 710 | 0.100 |
Why?
|
| Data Collection | 3 | 2023 | 3322 | 0.100 |
Why?
|
| Housing | 1 | 2017 | 670 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2020 | 1036 | 0.100 |
Why?
|
| Pain, Intractable | 1 | 2013 | 132 | 0.100 |
Why?
|
| Quality of Health Care | 2 | 2016 | 4330 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 865 | 0.100 |
Why?
|
| Obesity | 4 | 2024 | 12947 | 0.100 |
Why?
|
| Infertility, Male | 1 | 2015 | 395 | 0.100 |
Why?
|
| Myometrium | 1 | 2013 | 174 | 0.100 |
Why?
|
| Labor, Obstetric | 2 | 2016 | 323 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2019 | 9281 | 0.100 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 299 | 0.100 |
Why?
|
| Aged | 24 | 2024 | 169308 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2020 | 5079 | 0.100 |
Why?
|
| Sex Counseling | 1 | 2011 | 18 | 0.100 |
Why?
|
| Cholinergic Antagonists | 2 | 2023 | 168 | 0.100 |
Why?
|
| Umbilical Cord | 1 | 2013 | 177 | 0.100 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1964 | 0.100 |
Why?
|
| Labor Stage, Second | 1 | 2012 | 38 | 0.100 |
Why?
|
| Perinatology | 1 | 2012 | 63 | 0.100 |
Why?
|
| Public Health Practice | 1 | 2014 | 219 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 2 | 2020 | 2827 | 0.100 |
Why?
|
| Urban Population | 3 | 2017 | 2036 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 532 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 3205 | 0.100 |
Why?
|
| Single-Blind Method | 4 | 2018 | 1574 | 0.100 |
Why?
|
| South Carolina | 2 | 2022 | 100 | 0.100 |
Why?
|
| Fetal Death | 3 | 2020 | 435 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 846 | 0.100 |
Why?
|
| Echocardiography | 2 | 2015 | 4989 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 1858 | 0.090 |
Why?
|
| Urologic Surgical Procedures | 1 | 2014 | 298 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 222 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 21019 | 0.090 |
Why?
|
| Electronic Mail | 1 | 2013 | 213 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2024 | 3415 | 0.090 |
Why?
|
| Sex Preselection | 1 | 2010 | 16 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 22172 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 12990 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2018 | 1819 | 0.090 |
Why?
|
| Administration, Intravaginal | 2 | 2024 | 150 | 0.090 |
Why?
|
| Attitude | 1 | 2015 | 775 | 0.090 |
Why?
|
| Defecation | 1 | 2012 | 190 | 0.090 |
Why?
|
| Self Care | 1 | 2015 | 796 | 0.090 |
Why?
|
| Peritoneum | 1 | 2011 | 225 | 0.090 |
Why?
|
| Videotape Recording | 1 | 2012 | 337 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 275 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 2919 | 0.090 |
Why?
|
| Embryo Culture Techniques | 1 | 2010 | 84 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 2016 | 1152 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2568 | 0.080 |
Why?
|
| Parenting | 1 | 2015 | 701 | 0.080 |
Why?
|
| Child | 14 | 2024 | 80157 | 0.080 |
Why?
|
| Fecal Incontinence | 3 | 2019 | 241 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 4878 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2021 | 1722 | 0.080 |
Why?
|
| Thigh | 1 | 2010 | 241 | 0.080 |
Why?
|
| Estrogens | 1 | 2016 | 1522 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2015 | 768 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 255 | 0.080 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 616 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2020 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 330 | 0.080 |
Why?
|
| Follicular Fluid | 1 | 2009 | 92 | 0.080 |
Why?
|
| Sarcoma | 1 | 2020 | 1801 | 0.080 |
Why?
|
| Child, Preschool | 9 | 2024 | 42231 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2015 | 1255 | 0.080 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2011 | 328 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2012 | 2884 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2017 | 4575 | 0.080 |
Why?
|
| Oogenesis | 1 | 2009 | 124 | 0.080 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2008 | 47 | 0.080 |
Why?
|
| Decision Trees | 2 | 2021 | 504 | 0.080 |
Why?
|
| Paracentesis | 1 | 2008 | 98 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 2332 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2011 | 365 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2319 | 0.080 |
Why?
|
| Feedback | 1 | 2012 | 791 | 0.070 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 58983 | 0.070 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 7827 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 1943 | 0.070 |
Why?
|
| Poverty | 3 | 2024 | 2697 | 0.070 |
Why?
|
| Computer-Assisted Instruction | 1 | 2010 | 362 | 0.070 |
Why?
|
| Genome, Human | 2 | 2018 | 4425 | 0.070 |
Why?
|
| Pandemics | 6 | 2023 | 8656 | 0.070 |
Why?
|
| Fetus | 2 | 2019 | 1863 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 592 | 0.070 |
Why?
|
| Surgical Mesh | 3 | 2017 | 311 | 0.070 |
Why?
|
| Cytokines | 2 | 2023 | 7396 | 0.070 |
Why?
|
| Risk Assessment | 7 | 2020 | 23996 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2009 | 326 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1301 | 0.070 |
Why?
|
| Constipation | 3 | 2019 | 563 | 0.070 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 103 | 0.070 |
Why?
|
| Choice Behavior | 2 | 2024 | 824 | 0.070 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2006 | 19 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 1529 | 0.070 |
Why?
|
| Urodynamics | 2 | 2019 | 346 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 441 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 611 | 0.060 |
Why?
|
| Models, Educational | 1 | 2008 | 373 | 0.060 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 66 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 2169 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2008 | 307 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8553 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12463 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2017 | 3905 | 0.060 |
Why?
|
| Factor VIII | 1 | 2007 | 348 | 0.060 |
Why?
|
| Documentation | 1 | 2011 | 897 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2024 | 2330 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5799 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2011 | 711 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2017 | 2017 | 0.060 |
Why?
|
| Pregnancy Tests | 1 | 2024 | 33 | 0.060 |
Why?
|
| Sheep | 2 | 2008 | 1440 | 0.060 |
Why?
|
| Women's Health | 3 | 2024 | 2065 | 0.060 |
Why?
|
| Nurses | 1 | 2014 | 2478 | 0.060 |
Why?
|
| Clinical Clerkship | 1 | 2010 | 564 | 0.060 |
Why?
|
| Reference Values | 3 | 2007 | 4920 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 907 | 0.060 |
Why?
|
| Poisson Distribution | 2 | 2016 | 504 | 0.060 |
Why?
|
| Axilla | 2 | 2018 | 624 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 134 | 0.060 |
Why?
|
| Collagen | 2 | 2003 | 2638 | 0.060 |
Why?
|
| Telemedicine | 1 | 2022 | 3052 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2021 | 5492 | 0.060 |
Why?
|
| CpG Islands | 2 | 2020 | 1230 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 1190 | 0.060 |
Why?
|
| Orgasm | 1 | 2024 | 61 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5971 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 1085 | 0.060 |
Why?
|
| HIV Infections | 2 | 2021 | 17352 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2016 | 551 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 2422 | 0.060 |
Why?
|
| Prognosis | 7 | 2021 | 29629 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2007 | 459 | 0.050 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 580 | 0.050 |
Why?
|
| Self Report | 3 | 2020 | 3725 | 0.050 |
Why?
|
| Soaps | 1 | 2023 | 29 | 0.050 |
Why?
|
| Protein S | 1 | 2002 | 30 | 0.050 |
Why?
|
| Elbow Joint | 1 | 2007 | 359 | 0.050 |
Why?
|
| Gastric Bypass | 1 | 2011 | 818 | 0.050 |
Why?
|
| Mastectomy, Segmental | 2 | 2019 | 955 | 0.050 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 141 | 0.050 |
Why?
|
| Ankle Joint | 1 | 2007 | 446 | 0.050 |
Why?
|
| Sex Education | 2 | 2014 | 94 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 87 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 24 | 0.050 |
Why?
|
| Radiotherapy | 2 | 2020 | 1499 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 1674 | 0.050 |
Why?
|
| Models, Animal | 1 | 2008 | 2112 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5790 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2020 | 12130 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5841 | 0.050 |
Why?
|
| Blood Platelets | 2 | 2003 | 2479 | 0.050 |
Why?
|
| Ligaments | 1 | 2022 | 127 | 0.050 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 15843 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5293 | 0.050 |
Why?
|
| Perinatal Mortality | 1 | 2022 | 101 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2645 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8540 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9491 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2001 | 71 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2118 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 51 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2007 | 970 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13642 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2007 | 2217 | 0.050 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2020 | 28 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2202 | 0.050 |
Why?
|
| Synovitis | 1 | 2002 | 217 | 0.050 |
Why?
|
| Chickenpox | 1 | 2001 | 96 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11742 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7391 | 0.050 |
Why?
|
| Birth Certificates | 1 | 2020 | 71 | 0.040 |
Why?
|
| Observer Variation | 1 | 2007 | 2606 | 0.040 |
Why?
|
| Postmenopause | 2 | 2022 | 2513 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 2001 | 159 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2016 | 7967 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 254 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2018 | 11120 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1068 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3807 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2023 | 413 | 0.040 |
Why?
|
| Vitrification | 1 | 2020 | 51 | 0.040 |
Why?
|
| Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2014 | 212 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2684 | 0.040 |
Why?
|
| Curriculum | 3 | 2023 | 3743 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2020 | 2979 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2003 | 559 | 0.040 |
Why?
|
| Empathy | 1 | 2024 | 473 | 0.040 |
Why?
|
| Apgar Score | 1 | 2019 | 126 | 0.040 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 4761 | 0.040 |
Why?
|
| Intention | 1 | 2022 | 347 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6346 | 0.040 |
Why?
|
| Logistic Models | 4 | 2019 | 13255 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 15266 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 14665 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 817 | 0.040 |
Why?
|
| Cell Shape | 1 | 2020 | 371 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 794 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2005 | 1569 | 0.040 |
Why?
|
| Probability | 3 | 2012 | 2477 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2002 | 535 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 2209 | 0.040 |
Why?
|
| Lactation | 1 | 2021 | 397 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1080 | 0.040 |
Why?
|
| ROC Curve | 2 | 2019 | 3578 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2012 | 5496 | 0.040 |
Why?
|
| Educational Status | 2 | 2017 | 2522 | 0.040 |
Why?
|
| Uterus | 1 | 2022 | 649 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 778 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 1055 | 0.040 |
Why?
|
| Anger | 1 | 2020 | 406 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 311 | 0.040 |
Why?
|
| Knee Joint | 1 | 2007 | 1676 | 0.040 |
Why?
|
| Term Birth | 1 | 2018 | 138 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2018 | 2639 | 0.040 |
Why?
|
| Maternal-Child Health Centers | 1 | 2017 | 42 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2020 | 273 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2007 | 3424 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 745 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12341 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 1395 | 0.040 |
Why?
|
| Chorionic Villi | 1 | 2017 | 53 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1175 | 0.040 |
Why?
|
| Markov Chains | 1 | 2021 | 966 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2017 | 147 | 0.040 |
Why?
|
| Access to Information | 1 | 2020 | 316 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 12059 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 370 | 0.040 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2016 | 30 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2677 | 0.030 |
Why?
|
| Pain Measurement | 2 | 2020 | 3551 | 0.030 |
Why?
|
| Laparotomy | 1 | 2019 | 457 | 0.030 |
Why?
|
| Comprehension | 2 | 2012 | 621 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2021 | 491 | 0.030 |
Why?
|
| Israel | 1 | 2019 | 726 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 634 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2020 | 554 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2001 | 1173 | 0.030 |
Why?
|
| Vaginal Discharge | 1 | 2016 | 25 | 0.030 |
Why?
|
| Nocturia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 9469 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 552 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2020 | 697 | 0.030 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 128 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2015 | 86 | 0.030 |
Why?
|
| Health Literacy | 1 | 2020 | 444 | 0.030 |
Why?
|
| Hair | 1 | 2018 | 498 | 0.030 |
Why?
|
| Epigenomics | 1 | 2020 | 943 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2018 | 508 | 0.030 |
Why?
|
| Medicare | 2 | 2023 | 6770 | 0.030 |
Why?
|
| Sudan | 1 | 2014 | 86 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 701 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2016 | 188 | 0.030 |
Why?
|
| Uterine Hemorrhage | 1 | 2016 | 240 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2018 | 627 | 0.030 |
Why?
|
| Medical Staff | 1 | 2014 | 40 | 0.030 |
Why?
|
| Parturition | 1 | 2018 | 445 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1751 | 0.030 |
Why?
|
| World Health Organization | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 3358 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1351 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 713 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10194 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 726 | 0.030 |
Why?
|
| Quality of Life | 3 | 2023 | 13367 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2020 | 879 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2013 | 87 | 0.030 |
Why?
|
| New York | 1 | 2016 | 874 | 0.030 |
Why?
|
| Midwifery | 1 | 2015 | 124 | 0.030 |
Why?
|
| Constriction | 1 | 2013 | 168 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2122 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 8711 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7859 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2014 | 190 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 992 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 14607 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2001 | 2118 | 0.030 |
Why?
|
| Pregnancy in Adolescence | 1 | 2014 | 163 | 0.030 |
Why?
|
| Spouses | 1 | 2015 | 283 | 0.030 |
Why?
|
| Sutures | 1 | 2014 | 284 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2003 | 4001 | 0.030 |
Why?
|
| Cystocele | 1 | 2012 | 4 | 0.030 |
Why?
|
| Population Surveillance | 2 | 2014 | 2598 | 0.030 |
Why?
|
| Students | 1 | 2022 | 1741 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2013 | 177 | 0.030 |
Why?
|
| Bromocriptine | 1 | 2012 | 93 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 1460 | 0.030 |
Why?
|
| Rectocele | 1 | 2012 | 21 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 554 | 0.020 |
Why?
|
| Leiomyoma | 1 | 2017 | 636 | 0.020 |
Why?
|
| Linear Models | 2 | 2017 | 5872 | 0.020 |
Why?
|
| Hematocrit | 1 | 2013 | 623 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2018 | 1893 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 463 | 0.020 |
Why?
|
| Research Design | 2 | 2020 | 6180 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 2057 | 0.020 |
Why?
|
| Hernia | 1 | 2012 | 68 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2015 | 495 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2011 | 397 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 1784 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 413 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1664 | 0.020 |
Why?
|
| Individuality | 1 | 2012 | 301 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 703 | 0.020 |
Why?
|
| Birth Injuries | 1 | 2012 | 151 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4303 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2273 | 0.020 |
Why?
|
| Brachial Plexus | 1 | 2012 | 167 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2014 | 764 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2022 | 12794 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6312 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1363 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6484 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 2915 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1166 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1813 | 0.020 |
Why?
|
| Estradiol | 1 | 2017 | 1937 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 935 | 0.020 |
Why?
|
| Neural Tube Defects | 1 | 2012 | 255 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3415 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13510 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1648 | 0.020 |
Why?
|
| Mastectomy | 1 | 2018 | 1822 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 2003 | 771 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 409 | 0.020 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 6 | 0.020 |
Why?
|
| Platelet Activation | 2 | 2003 | 645 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4347 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 3080 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2021 | 2057 | 0.020 |
Why?
|
| Patient Participation | 1 | 2018 | 1445 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 426 | 0.020 |
Why?
|
| Medicaid | 1 | 2022 | 2818 | 0.020 |
Why?
|
| Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
| California | 1 | 2013 | 1430 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 5914 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6344 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8466 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 2491 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 2629 | 0.020 |
Why?
|
| Community Health Services | 1 | 2013 | 656 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2016 | 1520 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2017 | 2242 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3514 | 0.020 |
Why?
|
| Prolapse | 1 | 2007 | 63 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2012 | 553 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2557 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2013 | 662 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2008 | 161 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 2696 | 0.020 |
Why?
|
| Workflow | 1 | 2011 | 851 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2186 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 595 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 1204 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3848 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3530 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 321 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 36426 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1408 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 5073 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20099 | 0.020 |
Why?
|
| Minority Groups | 1 | 2013 | 1203 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6403 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2007 | 564 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15502 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1349 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 1447 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3728 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2008 | 683 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8528 | 0.010 |
Why?
|
| Ovary | 1 | 2008 | 959 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1732 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 30054 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
| Internal Medicine | 1 | 2011 | 1051 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 3023 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4915 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 306 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1668 | 0.010 |
Why?
|
| Forecasting | 1 | 2012 | 2928 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2002 | 100 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 116 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1120 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2012 | 2856 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 575 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11530 | 0.010 |
Why?
|
| Elbow | 1 | 2002 | 130 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12725 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8224 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1756 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 2656 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5247 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2011 | 2180 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2192 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1768 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10090 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18255 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3492 | 0.010 |
Why?
|
| Knee | 1 | 2002 | 279 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 1277 | 0.010 |
Why?
|
| Outpatients | 1 | 2008 | 1597 | 0.010 |
Why?
|
| Animals | 4 | 2021 | 168475 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3511 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1924 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 1515 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3929 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2005 | 492 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2016 | 4686 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4853 | 0.010 |
Why?
|
| Ankle | 1 | 2002 | 351 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 6056 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6019 | 0.010 |
Why?
|
| Heart | 1 | 2012 | 4404 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2002 | 888 | 0.010 |
Why?
|
| Chest Pain | 1 | 2005 | 1091 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14417 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10766 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1154 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2358 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 2113 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6241 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 4471 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5870 | 0.010 |
Why?
|
| Contrast Media | 1 | 2005 | 5307 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 8481 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 81539 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 11461 | 0.000 |
Why?
|
| Stroke | 1 | 2002 | 9758 | 0.000 |
Why?
|